Text this: Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

Export Ready —  

 _    _    __   __    ______   _    _     ______  
| |  | ||  \ \\/ //  /_   _// | || | ||  /_   _// 
| |/\| ||   \ ` //     | ||   | || | ||    | ||   
|  /\  ||    | ||     _| ||   | \\_/ ||   _| ||   
|_// \_||    |_||    /__//     \____//   /__//    
`-`   `-`    `-`'    `--`       `---`    `--`